LAURA MCKINNEY: Open Payments
NPI 1578094215 · MADISON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 20 payments from 11 companies in 2025. Trend: 2023 $88 · 2024 $126 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $62 |
| Lilly USA, LLC | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Novo Nordisk Inc | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| ABBVIE INC. | 2 | $39 |
| Dexcom, Inc. | 2 | $38 |
| Mannkind Corporation | 1 | $23 |
| Verona Pharma, Inc. | 1 | $20 |
| Insulet Corporation | 1 | $17 |
Products named: Veozah, AIRSUPRA, Ozempic, REXULTI, Dexcom G6 Transmitter, MOUNJARO, JARDIANCE, AFREZZA.
Industry payments across TN — which companies pay providers there.
